| Document Date: 2006-11-13 08:05:38
Open Document File Size: 246,24 KBShare Result on Facebook
Currency pence / / IndustryTerm beta-oxidation products / aqueous solutions / Prevention of Cardiovascular Disease / food / / MedicalCondition mixed dyslipidemia / chronic alcoholic liver disease / peripheral vascular disease / strokes / isolated hypertriglyceridemia / dysbetalipoproteinemia / hypertension / CHD / disease / atherosclerosis / hypertriglyceridemia / dysfunction / chronic / stroke / Dyslipidemia / diabetes / cardiovascular disease / human atherosclerosis / Renal Insufficiency / myocardial infarction / unstable angina / obesity / Renal disease / B disease / angina / coronary heart disease / proteinuria/albuminuria / fatal and non-fatal coronary heart disease / familial hypercholesterolemia / end-stage renal disease / renal dysfunction / hypercholesterolemia / Hepatic Insufficiency / / MedicalTreatment Hemodialysis / / Organization World Health Organization / Federal Communications Commission / DOSAGE AND ADMINISTRATION / / Person Cardiovascular Event / / / Position Major / / Product talc / triad / Simvastatin / TC / polyethylene glycol / Lipitor / BP / erythromycin / Lovastatin / / Technology Pharmacokinetics / Drug Metabolism / Pharmacodynamics / CVD / /
SocialTag |
Lipitor® (Atorvastatin Calcium) Tablets DESCRIPTION LIPITOR® (atorvastatin calcium) is a synthetic lipid-lowering agent. Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This